Geneva: The World Health Organisation (WHO) on Friday said it has suspended Gilead's Remdesivir from its so-called prequalification list (an…
New Delhi: Gilead Sciences Inc's remdesivir had little or no effect on the length of hospital stay of COVID patients…
New Delhi: Union Health Minister Dr Harsh Vardhan has said that the Centre is inspecting the coronavirus reinfection cases, along…
Adding an anti-inflammatory medicine to a drug already widely used for hospitalised COVID-19 patients shortens their recovery time by an…
Remdesivir has been launched under the brand name Remdac in the Indian market. Meant to treat patients suffering from severe…
Ahmedabad: If everything goes according to plan, Zydus Cadila will complete trials for its COVID-19 vaccine by February or March…
New York: Remdesivir, the anti-viral drug that has shown promise in the fight against COVID-19, has been backed by more…
New Delhi: Remdesivir will be available to patients in India this month. Mylan NV announced on Monday that the Drug…
New Delhi: Amid rising cases of coronavirus, there are reports about supply shortage and selling of two life-saving drugs —…
Bhubaneswar: About 1,200 strips of Fabi Flu (Favipiravir) tablets to cure patients with mild to moderate coronavirus are scheduled to…